Innate and adaptive immune responses to Leishmania
对利什曼原虫的先天和适应性免疫反应
基本信息
- 批准号:6777245
- 负责人:
- 金额:$ 33.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-05-01 至 2005-04-30
- 项目状态:已结题
- 来源:
- 关键词:LeishmaniaT lymphocyteantigen presenting cellcellular immunitydendritic cellsenzyme linked immunosorbent assaygel mobility shift assaygenetically modified animalshost organism interactionimmune responseimmunoglobulin Ginterleukin 10interleukin 12laboratory mouseleishmaniasisleukocyte activation /transformationmacrophagemicroorganism growthmicroorganism immunologyparasite infection mechanismtoll like receptorvirulence
项目摘要
The central hypothesis of this proposal is that Leishmania spp. are able to manipulate both the innate and the adaptive immune responses of the host to their advantage. The first aim of the proposal focuses on the ability of Leishmania to manipulate the innate immune response, and the second aim focuses on the ability of the parasite to manipulate the adaptive immune response. The proposal is built on two separate and surprising observations that were made in the lab. The first aim of the proposal is built on the observation that infection of macrophages and DC with Leishmania promastigotes fails to induce cytokine production or APC maturation. Thus we hypothesized that Leishmania fail to engage the innate immune responses of the host. The main question we will ask in Aim 1 is whether this failure to activate innate immunity is a critical
component to parasite virulence. To ask this question, we have developed transgenic Leishmania that do engage Toll-Like Receptors (TLRs) on macrophages and DC. We plan to study the biology of these organisms and determine whether they are presented to T cells differently, whether they cause lesions that are different from wild-type organisms, and whether they induce qualitatively and quantitatively different adaptive immune responses. The second aim is based on the observation that mice lacking the heavy chain of IgG (JH mice) are resistant to L. major infection, despite being on the susceptible BALB/c background. The infusion of immune serum into these mice actually increases lesion progression and parasite replication.
We plan to determine how IgG can work to the detriment of the host infected with an intracellular parasite. We hypothesize that IgG leads to IL-10 production by APCs, and we will determine the extent to which APCderived IL-10 influences adaptive immune responses to this organism. We will determine which aspects of the adaptive immune response are altered by the presence of IgG immune complexes. These studies not only pertain directly to Leishmania immunity, but they may also provide basic general information about theimmune resonse to intracellular pathogens, and about the role of APCs in modulating adaptive immune responses.
该提案的中心假设是利什曼原虫。能够操纵宿主的先天性和适应性免疫反应以发挥其优势。该提案的第一个目标侧重于利什曼原虫操纵先天免疫反应的能力,第二个目标侧重于寄生虫操纵适应性免疫反应的能力。该提议建立在实验室中进行的两个独立且令人惊讶的观察结果之上。该提案的第一个目标是建立在利什曼原虫前鞭毛体感染巨噬细胞和 DC 无法诱导细胞因子产生或 APC 成熟的观察基础上的。因此,我们假设利什曼原虫无法参与宿主的先天免疫反应。我们在目标 1 中要问的主要问题是,激活先天免疫的失败是否是一个关键问题?
寄生虫毒力的组成部分。为了提出这个问题,我们开发了转基因利什曼原虫,它确实与巨噬细胞和 DC 上的 Toll 样受体 (TLR) 结合。我们计划研究这些生物体的生物学,并确定它们是否以不同的方式呈递给 T 细胞,它们是否引起与野生型生物体不同的病变,以及它们是否诱导定性和定量不同的适应性免疫反应。第二个目标是基于以下观察结果:缺乏 IgG 重链的小鼠(JH 小鼠)尽管处于易感 BALB/c 背景下,但对硕大利斯特菌感染有抵抗力。将免疫血清输注到这些小鼠体内实际上会增加病变进展和寄生虫复制。
我们计划确定 IgG 如何对感染细胞内寄生虫的宿主造成损害。我们假设 IgG 导致 APC 产生 IL-10,并且我们将确定 APC 衍生的 IL-10 在多大程度上影响对该生物体的适应性免疫反应。我们将确定 IgG 免疫复合物的存在会改变适应性免疫反应的哪些方面。这些研究不仅直接涉及利什曼原虫免疫,而且还可能提供有关细胞内病原体免疫反应以及 APC 在调节适应性免疫反应中的作用的基本一般信息。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A role for IgG immune complexes during infection with the intracellular pathogen Leishmania.
IgG免疫复合物在感染Leishmania的感染过程中的作用。
- DOI:10.1084/jem.20041470
- 发表时间:2005-03-07
- 期刊:
- 影响因子:15.3
- 作者:Miles, SA;Conrad, SM;Aves, RG;Jeronimo, SMB;Mosser, DM
- 通讯作者:Mosser, DM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID M MOSSER其他文献
DAVID M MOSSER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID M MOSSER', 18)}}的其他基金
Treating collagen-induced arthritis (CIA) with immunoregulatory nanoparticles
用免疫调节纳米颗粒治疗胶原诱导的关节炎 (CIA)
- 批准号:
9047174 - 财政年份:2016
- 资助金额:
$ 33.41万 - 项目类别:
Treating collagen-induced arthritis (CIA) with immunoregulatory nanoparticles
用免疫调节纳米颗粒治疗胶原诱导的关节炎 (CIA)
- 批准号:
9378465 - 财政年份:2016
- 资助金额:
$ 33.41万 - 项目类别:
Regulatory macrophages and the host inflammatory response
调节性巨噬细胞和宿主炎症反应
- 批准号:
9021661 - 财政年份:2013
- 资助金额:
$ 33.41万 - 项目类别:
Regulatory macrophages and the host inflammatory response
调节性巨噬细胞和宿主炎症反应
- 批准号:
8642658 - 财政年份:2013
- 资助金额:
$ 33.41万 - 项目类别:
Regulatory macrophages and the host inflammatory response
调节性巨噬细胞和宿主炎症反应
- 批准号:
8504342 - 财政年份:2013
- 资助金额:
$ 33.41万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 33.41万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 33.41万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 33.41万 - 项目类别:
Discovery Grants Program - Individual